Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
8.2800
+1.8100 (27.98%)
NASDAQ · Last Trade: Jul 24th, 12:44 PM EDT
Detailed Quote
Previous Close | 6.470 |
---|---|
Open | 7.750 |
Bid | 8.280 |
Ask | 8.370 |
Day's Range | 7.130 - 8.468 |
52 Week Range | 4.400 - 33.66 |
Volume | 10,319,089 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 409,823 |
Chart
News & Press Releases
Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths
By Liminatus Pharma Inc. · Via GlobeNewswire · July 24, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · July 24, 2025
Via Benzinga · July 24, 2025
Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovation
By Liminatus Pharma Inc. · Via GlobeNewswire · July 22, 2025
Via Benzinga · July 17, 2025
Via Benzinga · July 10, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 3, 2025
U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.
Via Benzinga · July 2, 2025
Via Benzinga · June 30, 2025
Via Benzinga · June 26, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 24, 2025
Via Benzinga · June 24, 2025
Via Benzinga · June 20, 2025
Via Benzinga · June 18, 2025
Via Benzinga · June 17, 2025
Via Benzinga · June 13, 2025
Via Benzinga · June 13, 2025
Via Benzinga · June 12, 2025